PKS Advisory Services’s AbbVie ABBV Stock Holding History

PKS Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$856K	Sell	3,404 -164	-5%	-$35.3K	0.14%	150
2026 Q1	$775K	Buy	3,568 +85	+2%	+$18.9K	0.18%	115
2025 Q4	$796K	Sell	3,483 -1,463	-30%	-$333K	0.18%	109
2025 Q3	$800K	Buy	4,946 +1,234	+33%	+$251K	0.17%	109
2025 Q2	$689K	Buy	3,712 +23	+0.6%	+$4.28K	0.17%	116
2025 Q1	$771K	Sell	3,689 -160	-4%	-$31.1K	0.21%	101
2024 Q4	$684K	Buy	+3,849	New	+$708K	0.17%	110

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PKS Advisory Services's ABBV Position: Q2 2026 in Review

PKS Advisory Services reduced its AbbVie (ABBV) stake by 4.6% in Q2 2026, selling an estimated $35.3K and leaving 3,404 shares worth $856K. The position accounts for 0.14% of the portfolio, ranked #150.

PKS Advisory Services first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

PKS Advisory Services held 3,404 shares of AbbVie worth $856K as of Q2 2026.
PKS Advisory Services sold 164 AbbVie shares in Q2 2026, an estimated $35.3K.
AbbVie made up 0.14% of PKS Advisory Services's portfolio in Q2 2026, its #150 holding.
PKS Advisory Services first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PKS Advisory Services's 13F filing for Q2 2026, filed 4 Aug 2026.